Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (8): 828-832.DOI: 10.3969/j.issn.1673-8640.2021.08.010
Previous Articles Next Articles
WANG Yu, ZHANG Wenwen, LIU Meiling, LIU Xiaojuan
Received:2020-03-25
Online:2021-08-30
Published:2021-08-30
CLC Number:
WANG Yu, ZHANG Wenwen, LIU Meiling, LIU Xiaojuan. Relationship between AFP,free-βHCG,uE3 and GDM in the second trimester of pregnancy[J]. Laboratory Medicine, 2021, 36(8): 828-832.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.08.010
| 组别 | 例数 | 年龄/岁 | BMI/ (kg/m2) | 孕周/周 | 收缩压/kPa | 舒张压/kPa | FBG/(mmol/L) | 餐后1 h血糖/(mmol/L) |
|---|---|---|---|---|---|---|---|---|
| GDM组 | 378 | 29.61±5.90 | 22.36±1.45 | 17.02±1.09 | 15.16±1.38 | 9.87±1.15 | 4.97±0.55 | 7.83±1.78 |
| 正常妊娠组 | 16 627 | 28.35±5.42 | 21.97±1.53 | 16.96±1.16 | 15.72±1.22 | 9.50±1.27 | 4.62±0.59 | 7.29±1.86 |
| t值 | 4.469 | 4.913 | 1.002 | 0.886 | 1.642 | 11.425 | 5.591 | |
| P值 | 0.000 | 0.000 | 0.319 | 0.379 | 0.100 | 0.000 | 0.000 | |
| 组别 | 餐后2 h血糖/(mmol/L) | TC/ (mmol/L) | TG/ (mmol/L) | HDL-C/(mmol/L) | LDL-C/(mmol/L) | AFP MoM | free-βHCG MoM | uE3 MoM |
| GDM组 | 6.75±1.33 | 5.46±1.09 | 2.53±0.86 | 2.02±1.05 | 2.98±0.87 | 1.79±0.41 | 1.82±0.30 | 0.65±0.07 |
| 正常妊娠组 | 6.08±1.28 | 5.38±1.02 | 2.49±0.90 | 2.07±1.00 | 3.03±0.93 | 1.13±0.38 | 1.09±0.24 | 0.94±0.08 |
| t值 | 10.057 | 1.512 | 0.869 | -0.964 | -1.045 | 33.336 | 58.114 | -69.872 |
| P值 | 0.000 | 0.132 | 0.392 | 0.337 | 0.301 | 0.000 | 0.000 | 0.000 |
| 组别 | 例数 | 年龄/岁 | BMI/ (kg/m2) | 孕周/周 | 收缩压/kPa | 舒张压/kPa | FBG/(mmol/L) | 餐后1 h血糖/(mmol/L) |
|---|---|---|---|---|---|---|---|---|
| GDM组 | 378 | 29.61±5.90 | 22.36±1.45 | 17.02±1.09 | 15.16±1.38 | 9.87±1.15 | 4.97±0.55 | 7.83±1.78 |
| 正常妊娠组 | 16 627 | 28.35±5.42 | 21.97±1.53 | 16.96±1.16 | 15.72±1.22 | 9.50±1.27 | 4.62±0.59 | 7.29±1.86 |
| t值 | 4.469 | 4.913 | 1.002 | 0.886 | 1.642 | 11.425 | 5.591 | |
| P值 | 0.000 | 0.000 | 0.319 | 0.379 | 0.100 | 0.000 | 0.000 | |
| 组别 | 餐后2 h血糖/(mmol/L) | TC/ (mmol/L) | TG/ (mmol/L) | HDL-C/(mmol/L) | LDL-C/(mmol/L) | AFP MoM | free-βHCG MoM | uE3 MoM |
| GDM组 | 6.75±1.33 | 5.46±1.09 | 2.53±0.86 | 2.02±1.05 | 2.98±0.87 | 1.79±0.41 | 1.82±0.30 | 0.65±0.07 |
| 正常妊娠组 | 6.08±1.28 | 5.38±1.02 | 2.49±0.90 | 2.07±1.00 | 3.03±0.93 | 1.13±0.38 | 1.09±0.24 | 0.94±0.08 |
| t值 | 10.057 | 1.512 | 0.869 | -0.964 | -1.045 | 33.336 | 58.114 | -69.872 |
| P值 | 0.000 | 0.132 | 0.392 | 0.337 | 0.301 | 0.000 | 0.000 | 0.000 |
| 项目 | OR值(95%CI) | 回归系数 | 标准误 | Wald χ2值 | P值 |
|---|---|---|---|---|---|
| 年龄 | 1.093(1.021~1.135) | 0.089 | 0.016 | 3.735 | 0.044 |
| BMI | 1.107(1.058~1.249) | 0.102 | 0.015 | 4.102 | 0.041 |
| FBG | 1.359(1.167~1.560) | 0.307 | 0.073 | 3.938 | 0.046 |
| 餐后1 h血糖 | 1.587(1.224~1.813) | 0.462 | 0.026 | 4.164 | 0.037 |
| 餐后2 h血糖 | 1.520(1.372~1.796) | 0.419 | 0.101 | 4.578 | 0.032 |
| AFP MoM | 1.254(1.103~1.458) | 0.226 | 0.032 | 6.829 | 0.009 |
| free-βHCG MoM | 1.242(1.076~1.412) | 0.217 | 0.024 | 5.732 | 0.014 |
| uE3 MoM | 0.901(0.864~0.956) | -0.104 | 0.019 | 5.136 | 0.022 |
| 项目 | OR值(95%CI) | 回归系数 | 标准误 | Wald χ2值 | P值 |
|---|---|---|---|---|---|
| 年龄 | 1.093(1.021~1.135) | 0.089 | 0.016 | 3.735 | 0.044 |
| BMI | 1.107(1.058~1.249) | 0.102 | 0.015 | 4.102 | 0.041 |
| FBG | 1.359(1.167~1.560) | 0.307 | 0.073 | 3.938 | 0.046 |
| 餐后1 h血糖 | 1.587(1.224~1.813) | 0.462 | 0.026 | 4.164 | 0.037 |
| 餐后2 h血糖 | 1.520(1.372~1.796) | 0.419 | 0.101 | 4.578 | 0.032 |
| AFP MoM | 1.254(1.103~1.458) | 0.226 | 0.032 | 6.829 | 0.009 |
| free-βHCG MoM | 1.242(1.076~1.412) | 0.217 | 0.024 | 5.732 | 0.014 |
| uE3 MoM | 0.901(0.864~0.956) | -0.104 | 0.019 | 5.136 | 0.022 |
| [1] | 吴燕华, 董琛琛, 廖奇峰. 脂联素、瘦素水平变化对妊娠糖尿病孕妇发病率的影响[J]. 实用糖尿病杂志, 2020, 16(5):107-108. |
| [2] | 张艳, 高慧, 苏妍. HbA1c、TAC、FRU及SHBG联合诊断对妊娠期糖尿病早诊断的临床价值[J]. 新疆医科大学学报, 2019, 42(11):1456-1458. |
| [3] | 周伟丽, 柴霖, 耿淑敏. 孕中期血清学指标产前筛查对胎儿染色体异常及妊娠结局的指导意义[J]. 中国妇幼保健, 2019, 34(19):4505-4508. |
| [4] | 冯建丽, 沈国松. 颈项透明层厚度及血清标志物与病理妊娠的关系[J]. 中国现代医学杂志, 2018, 28(8):66-70. |
| [5] | KÖSÜS N, KÖSÜS A, DURAN M, et al. Effect of underlying infertility factors on second trimester serum screening results[J]. J Reprod Med, 2014, 59(1-2):76-80. |
| [6] | 朱翔, 许芳, 王玉萍, 等. 8 606例中孕期妇女血清学三联筛查及产前诊断结果分析[J]. 皖南医学院学报, 2016, 35(6):568-571. |
| [7] | 郭方方. 孕中期唐氏筛查血清标志物结果与病理妊娠的关系[J]. 中国当代医药, 2019, 26(17):92-94. |
| [8] | 周畅, 王亚南. 首次孕检空腹血糖在妊娠期糖尿病诊断中的价值[J]. 重庆医学, 2014, 43(36):4941-4943. |
| [9] | 季永军, 张旭. 妊娠期糖尿病118例临床分析[J]. 皖南医学院学报, 2014, 33(6):525-527. |
| [10] | 卢云飞, 纪美晶, 王锐, 等. 孕妇基础25-羟维生素D水平与孕中期血脂代谢及妊娠期糖尿病相关性研究[J]. 河北医药, 2018, 40(21):3245-3248. |
| [11] |
STEYN A, CROWTHER N J, NORRIS S A, et al. Epigenetic modification of the pentose phosphate pathway and the IGF-axis in women with gestational diabetes mellitus[J]. Epigenomics, 2019, 11(12):1371-1385.
DOI URL |
| [12] | 于璐, 吕巍. 唐氏综合征中孕期血清学筛查中MOM值稳定性的探讨[J]. 中国优生与遗传杂志, 2019, 27(8):946-948. |
| [13] | 南燕燕, 李娜, 董智力. 孕中期唐氏筛查血清标志物及miR-200C与病理妊娠的关系[J]. 临床和实验医学杂志, 2018, 17(2):188-192. |
| [14] | 林松, 涂文瑞. AFP、uE3、free β-HCG联检对孕中期妇女胎儿缺陷筛查有效性及影响因素分析[J]. 标记免疫分析与临床, 2012, 19(1):11-13. |
| [15] | 林峰芳, 孙霞. Logistic回归和ROC曲线分析孕酮、β-HCG、CA125对早期先兆流产患者妊娠结局的诊断价值[J]. 医学研究杂志, 2018, 47(1):152-155. |
| [16] |
WILGEN U, PRETORIUS C J, GOUS R S, et al. Hook effect in Abbott i-STAT β-human chorionic gonadotropin(β-hCG) point of care assay[J]. Clin Biochem, 2014, 47(13-14):1320-1322.
DOI URL |
| [17] |
REN F, HU Y U, ZHOU H, et al. Second trimester maternal serum triple screening marker levels in normal twin and singleton pregnancies[J]. Biomed Rep, 2016, 4(4):475-478.
DOI URL |
| [18] |
SETTIYANAN T, WANAPIRAK C, SIRICHOTIYAKUL S, et al. Association between isolated abnormal levels of maternal serum unconjugated estriol in the second trimester and adverse pregnancy outcomes[J]. J Matern Fetal Neonatal Med, 2016, 29(13):2093-2097.
DOI URL |
| [19] | 潘旭, 郭文晴, 陈元花, 等. 8 264例住院孕妇妊娠期糖尿病的发病率及其危险因素分析[J]. 现代预防医学, 2019, 46(20):3719-3723. |
| [20] |
CHU S Y, CALLAGHAN W M, KIM S Y, et al. Maternal obesity and risk of gestational diabetes mellitus[J]. Diabetes Care, 2007, 30(8):2070-2076.
DOI URL |
| [21] |
RATNER L D, STEVENS G, BONAVENTURA M M, et al. Hyperprolactinemia induced by hCG leads to metabolic disturbances in female mice[J]. J Endocrinol, 2016, 230(1):157-169.
DOI URL |
| [1] | CHEN Hui, CHEN Guanghui, LIANG Yingliang, WANG Wandang, YIN Zhijun. Screening hub genes and diagnostic analysis of gestational diabetes mellitus based on GEO database [J]. Laboratory Medicine, 2023, 38(3): 276-281. |
| [2] | KE Qiulei, HUANG Jing, CHEN Aizheng, SONG Yanfeng, SU Xiaofeng. Subgingival flora and the relations between periodontal health indexes and risk of periodontal disease in patients with GDM [J]. Laboratory Medicine, 2023, 38(2): 163-166. |
| [3] | QIAN Linyu, LIANG Weifang, TANG Sichen. Determination and clinical significance of NLRP3,CTRP6 and IL-1β in patients with gestational diabetes mellitus [J]. Laboratory Medicine, 2023, 38(10): 936-940. |
| [4] | WANG Lingling, REN Chunli. Correlation of MTHFR gene C677T polymorphism and blood lipid levels with GDM [J]. Laboratory Medicine, 2022, 37(6): 543-546. |
| [5] | ZHANG Xiaoqin, ZHOU Yulan, FU Zhumei, HAN Xuexue, ZHAN Jie. Relationship of mtDNA T16189C mutation and gestational diabetes mellitus [J]. Laboratory Medicine, 2022, 37(5): 413-416. |
| [6] | LE Jiangman, LI Tianyuan, TAN Meiyu, WANG Yajie, ZHOU Lida, SHU Jie, WU Jiaoxiang, SUN Hanxiao, XUAN Binbin, CAI Xushan, SHENG Huiming. Correlation of gestational diabetes mellitus with plasma TMAO [J]. Laboratory Medicine, 2021, 36(8): 795-799. |
| [7] | ZHOU Lifang, PAN Shun, TANG Zhenhua. Application of Raman spectroscopy in the diagnosis of gestational diabetes mellitus [J]. Laboratory Medicine, 2021, 36(3): 313-317. |
| [8] | XU Zhen, MA Lijuan, WU Siyi, WANG Yan, JIA Keke. Predictive role of serum fibronectin level in the second trimester of pregnancy for patients with gestational diabetes mellitus complicated with preeclampsia [J]. Laboratory Medicine, 2020, 35(6): 561-565. |
| [9] | YOU Xiuzhen. Predictive value of body mass index and triglyceride level changes in early pregnancy on gestational diabetes mellitus [J]. Laboratory Medicine, 2019, 34(9): 831-834. |
| [10] | ZHANG Kainan, ZHANG Zhaoxia. Role of gut microbiota in gestational obesity and diabetes mellitus [J]. Laboratory Medicine, 2019, 34(3): 276-279. |
| [11] | JIN Yuewen, YUE Chaoyan, YING Chunmei. Roles of glycated hemoglobin A1c and glycated albumin in screening gestational diabetes mellitus among elderly pregnant women [J]. Laboratory Medicine, 2018, 33(4): 312-315. |
| [12] | ZHANG Chunyi, NI Yinghua, JI Xin, YING Chunmei. Correlation of neonate birth weight with glycated hemoglobin A1c and glycated albumin levels in patients with gestational diabetes mellitus [J]. Laboratory Medicine, 2017, 32(3): 165-168. |
| [13] | ZHANG Xianghui, ZHAO Yuanming, SUN Zhuoxiang, CHENG Panpan, JIN Chao. Correlation study of serum ferritin and high-sensitivity C reactive protein in gestational diabetes mellitus [J]. Laboratory Medicine, 2015, 30(9): 903-905. |
| [14] | ZONG Yingying, XU Hao, XU Wei, GU Yuming, ZU Maoheng, WAN Haoguang, WU Kang. Evaluation on the diagnostic significance of DKK1, GP73 and AFP in primary hepatic carcinoma by Logisitic regression analysis and ROC curve analysis [J]. Laboratory Medicine, 2015, 30(6): 559-563. |
| [15] | SUN Xueqing, SONG Dewei, XU Bei, WU Liqing, HU Gaofei, LI Hongmei. Advances in the research for the quantitative method of alpha fetoprotein [J]. Laboratory Medicine, 2015, 30(4): 397-402. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||